AMGEN Inc.
NASDAQ:AMGN 4:00:00 PM EDT
Other Pre-Announcement
Amgen - QTRLY Earnings Per Share $3.00; QTRLY Adjusted Earnings Per Share $4.09
Published: 01/31/2023 21:45 GMT
AMGEN Inc. (AMGN) - Amgen - Qtrly Total Product Sales Up 4%.
Amgen - Qtrly Earnings per Share $3.00; Qtrly Adjusted Earnings per Share $4.09.
Amgen Inc Q4 Earnings per Share View $4.10, Revenue View $6.77 Billion -- Refinitiv Ibes Data (analyst estimates).
Amgen - Qtrly Total Revenue $6.8 Billion, Largely Unchanged From Q4 2021.
Amgen - Sees 2023 Earnings per Share $13.16 to $14.41, Excluding Contribution From Horizon Therapeutics.
Amgen - Sees 2023 Total Revenue $26.0 Billion to $27.2 Billion, Excluding Contribution From Horizon Therapeutics.
Amgen Inc FY2023 Earnings per Share View $18.43, Revenue View $27.12 Billion -- Refinitiv Ibes Data (analyst estimates).
Amgen - Sees 2023 Adjusted Earnings per Share $17.40 to $18.60, Excluding Contribution From Horizon Therapeutics.
Amgen - Sees 2023 Capex About $925 Million, Excluding Contribution From Horizon Therapeutics.
Amgen - Qtrly Earnings per Share $3.00; Qtrly Adjusted Earnings per Share $4.09.
Amgen Inc Q4 Earnings per Share View $4.10, Revenue View $6.77 Billion -- Refinitiv Ibes Data (analyst estimates).
Amgen - Qtrly Total Revenue $6.8 Billion, Largely Unchanged From Q4 2021.
Amgen - Sees 2023 Earnings per Share $13.16 to $14.41, Excluding Contribution From Horizon Therapeutics.
Amgen - Sees 2023 Total Revenue $26.0 Billion to $27.2 Billion, Excluding Contribution From Horizon Therapeutics.
Amgen Inc FY2023 Earnings per Share View $18.43, Revenue View $27.12 Billion -- Refinitiv Ibes Data (analyst estimates).
Amgen - Sees 2023 Adjusted Earnings per Share $17.40 to $18.60, Excluding Contribution From Horizon Therapeutics.
Amgen - Sees 2023 Capex About $925 Million, Excluding Contribution From Horizon Therapeutics.